For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Immunome Inc (NASDAQ: IMNM) closed the day trading at $9.90 down -11.09% from the previous closing price of $11.14. In other words, the price has decreased by -$11.09 from its previous closing price. On the day, 3.17 million shares were traded. IMNM stock price reached its highest trading level at $11.19 during the session, while it also had its lowest trading level at $9.635.
Ratios:
For a better understanding of IMNM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.JP Morgan initiated its Overweight rating on April 30, 2024, with a $24 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 19 ’24 when Rosett Max sold 14,380 shares for $16.01 per share. The transaction valued at 230,224 led to the insider holds 47,476 shares of the business.
Rosett Max bought 14,380 shares of IMNM for $230,211 on Sep 19 ’24. On Aug 16 ’24, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $13.94 each. As a result, the insider paid 97,608 and bolstered with 16,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 618238400 and an Enterprise Value of 378108864. For the stock, the TTM Price-to-Sale (P/S) ratio is 54.26 while its Price-to-Book (P/B) ratio in mrq is 2.78. Its current Enterprise Value per Revenue stands at 37.329 whereas that against EBITDA is -3.424.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $6.93. The 50-Day Moving Average of the stock is -24.50%, while the 200-Day Moving Average is calculated to be -38.84%.
Shares Statistics:
Over the past 3-months, IMNM traded about 616.36K shares per day on average, while over the past 10 days, IMNM traded about 890760 shares per day. A total of 62.42M shares are outstanding, with a floating share count of 50.90M. Insiders hold about 18.46% of the company’s shares, while institutions hold 82.32% stake in the company. Shares short for IMNM as of 1730332800 were 10468711 with a Short Ratio of 16.98, compared to 1727654400 on 12878019. Therefore, it implies a Short% of Shares Outstanding of 10468711 and a Short% of Float of 17.740000000000002.
